Food, drugs, devices › Centurion Medical Products Corporation
Device recall: EPISTAXIS TRAY Kit Code: MNS10165
FDA enforcement event 83359 is a device recall by Centurion Medical Products Corporation of Williamston, MI, initiated 24 Jun 2019 and classified Class II, with 3 product records.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.
Status: Terminated, terminated 24 Jul 2020. Initiation: voluntary: firm initiated. Centurion Medical Products Corporation has 19 enforcement events on this register, with a median of 2 product records per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Centurion Medical Products Corporation, Williamston, MI.
Reason for recall
"Various medical device kits contain MAJOR Nasal Decongestant Spray is being recalled by the manufacturer"
Distribution
"CT, IL"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-0407-2020 | EPISTAXIS TRAY Kit Code: MNS10165 | 525 Kits | Class II | Terminated | 27 Nov 2019 |
| Z-0408-2020 | YNHH SCOPE KIT Kit Code: MNS10475 | 644 Kits | Class II | Terminated | 27 Nov 2019 |
| Z-0409-2020 | NOSEBLEED TRAY Kit Code: MNS3885 | 30 Kits | Class II | Terminated | 27 Nov 2019 |
Context
Other enforcement events for Centurion Medical Products Corporation
All 19 events for Centurion Medical Products Corporation
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "Various medical device kits contain MAJOR Nasal Decongestant Spray is being recalled by the manufacturer"
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "CT, IL"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 24 Jul 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.